Intervention not reported
Withdrawals due to adverse events · participants with rheumatoid arthritis and with partial response to MTX
The intervention showed no clear difference in withdrawals due to adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · participants with rheumatoid arthritis and with partial response to MTX
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious infections · participants with rheumatoid arthritis and with partial response to MTX
1 finding from 1 review
Intervention not reported
Serious infections · participants with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Outcome: ACR50 ‐ American College of Rheumatology Improvement Criteria · participants with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Remission Achievement of disease activity score < 2.6 · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention leads to higher remission Achievement of disease activity score < 2.6 (high certainty).
1 finding from 1 review
Intervention not reported
Reduction in disability score Health Assessment Questionnaire. Scale from: 0 to 3 · participants with rheumatoid arthritis and with a partial response to DMARDs
1 finding from 1 review
Intervention not reported
Radiographic progression Total Sharp Score Scale from: 0 to 448 · participants with rheumatoid arthritis and with a partial response to DMARDs
1 finding from 1 review
Intervention not reported
Withdrawals due to adverse events · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention showed no clear difference in withdrawals due to adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious infections · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention showed no clear difference in serious infections (high certainty).
1 finding from 1 review
Intervention not reported
ACR50 American College of Rheumatology improvement criteria · participants with rheumatoid arthritis and with partial response to MTX
The intervention probably leads to higher ACR50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
Remission Disease activity score < 2.6 · participants with rheumatoid arthritis and with partial response to MTX
1 finding from 1 review